These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Fluorescent mesoporous silica nanotubes incorporating CdS quantum dots for controlled release of ibuprofen.
    Author: Yang YJ, Tao X, Hou Q, Chen JF.
    Journal: Acta Biomater; 2009 Nov; 5(9):3488-96. PubMed ID: 19442764.
    Abstract:
    Mesoporous silica nanotubes (MSNTs) and amine-functionalized MSNTs (NH(2)-MSNTs) have been successfully synthesized via a sol-gel route using needle-like CaCO(3) nanoparticles as inorganic templates and post-modification with 3-aminopropyltriethoxysilane. Subsequently, the preformed nanotubes were functionalized with blue fluorescent CdS quantum dots, as demonstrated by transmission electron microscopy and confocal laser scanning microscopy. The morphology and microstructure of the produced materials were characterized by scanning electron microscopy and N(2) adsorption-desorption measurements. A comparative study of the capacity of several kinds of nanotube materials to store ibuprofen indicated that the drug-loading amount in CdS-NH(2)-MSNTs (CdS-incorporated NH(2)-MSNTs) could reach up to 740 mg/g silica, similar to that in as-prepared MSNTs (762 mg/g silica) and NH(2)-MSNTs (775 mg/g silica). Drug release studies in simulated body fluid revealed that the loaded ibuprofen released from amine-functionalized systems at a significantly lower release rate as compared to that from amine-free systems, and the incorporation of CdS quantum dots had nearly no effect on the ibuprofen release process. Further study on the ibuprofen release from CdS-NH(2)-MSNTs in other media, i.e. borate buffer saline, pure water and normal saline, indicated that CdS-NH(2)-MSNTs are pH- and ion-sensitive drug carriers, which should facilitate controlled drug delivery and disease therapy.
    [Abstract] [Full Text] [Related] [New Search]